This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Sami Labs Limited, Other. Active years: 2015.
Company Filing History:

Years Active: 2015
Title: Innovations by Krishnamani Jayaraman
Introduction
Krishnamani Jayaraman is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of bioavailable stilbenoids, focusing on their therapeutic applications. With a total of 3 patents, his work has garnered attention for its potential impact on health and wellness.
Latest Patents
Jayaraman's latest patents include innovative compositions that utilize orally bioavailable stilbenoids. One of his key inventions is a novel stilbenoid, 3,5-dimethoxy-3,4'-dihydroxystilbene, which has shown an unexpected ability to prevent lipid accumulation during adipocyte differentiation. This discovery has implications for anti-obesity and anti-cellulite therapies. Additionally, his research highlights the enhanced activation of SIRT-1 by this compound, surpassing the effects of resveratrol and its natural analog, pterostilbene. His work also includes sirtuin modulating compositions that enhance SIRT-1 activity, showcasing the potential for new therapeutic applications.
Career Highlights
Throughout his career, Krishnamani Jayaraman has worked with various organizations, including Sami Labs Limited. His expertise in the field of bioactive compounds has positioned him as a leading figure in the development of nutraceuticals and cosmeceuticals.
Collaborations
Jayaraman has collaborated with notable professionals in his field, including Muhammed Majeed and Kalyanam Nagabhushanam. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Krishnamani Jayaraman's contributions to the field of bioavailable stilbenoids and their therapeutic applications highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in nutraceutical and cosmeceutical research.